| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAD51 paralog C | 0.533 | 0.692 | 6.2E-14 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAD51 paralog D | 0.674 | 0.385 | 1.1E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
FRAT regulator of WNT signaling pathway 1 | 0.653 | 0.462 | 0.32 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
gastric carcinoma proliferation enhancing transcript 1 | 0.647 | 0.308 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
mitochondrial calcium uptake 1 | 0.638 | 0.654 | 1.9E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
calcium and integrin binding family member 2 | 0.545 | 0.808 | 1.4E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
importin 7 | 0.729 | 0.269 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
GIPC PDZ domain containing family member 1 | 0.628 | 0.577 | 8.3E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
MALT1 paracaspase | 0.532 | 0.769 | 0.99 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
egl-9 family hypoxia inducible factor 2 | 0.604 | 0.731 | 0.72 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
crystallin gamma C | 0.612 | 0.577 | 6.1E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
adenylosuccinate lyase | 0.631 | 0.654 | 8.9E-12 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | 0.769 | 0.269 | 1.1E-09 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
eukaryotic translation initiation factor 4 gamma 1 | 0.553 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
crystallin gamma E, pseudogene | 0.666 | 0.538 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
two pore segment channel 2 | 0.760 | 0.346 | 3.1E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
ninein like | 0.682 | 0.538 | 2.7E-39 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
TRAF2 and NCK interacting kinase | 0.612 | 0.615 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
endonuclease domain containing 1 | 0.839 | 0.192 | 6.6E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
integrin subunit beta 3 binding protein | 0.792 | 0.269 | 3.0E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
cell adhesion molecule 2 | 0.670 | 0.538 | 0.89 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
pre-mRNA processing factor 31 | 0.531 | 0.731 | 0.98 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 |